Page last updated: 2024-09-02

ecteinascidin 743 and Synovioma

ecteinascidin 743 has been researched along with Synovioma in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	5 (71.43)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Caldari, E; De Paolis, M; Fiore, M; Giannini, C; Pirini, MG; Sambri, A; Spinnato, P; Zucchini, R	1
Desar, IME; Fleuren, EDG; van der Graaf, WTA	1
Basso, U; Maruzzo, M; Montesco, MC; Rastrelli, M; Roma, A; Zanardi, E	1
Baldi, GG; Benson, C; Blay, JY; Casali, PG; Constantinidou, A; Contu, M; Dei Tos, AP; Dileo, P; Le Cesne, A; Sanfilippo, R; Vizzini, L	1
Grignani, G; Martín-Broto, J; Reichardt, P; Schuler, M	1
Araki, N; Hamada, K; Imura, Y; Itoh, K; Myoui, A; Naka, N; Nakai, T; Outani, H; Sasagawa, S; Takenaka, S; Yamada, S; Yasui, H; Yoshikawa, H	1
Beijnen, JH; Beumer, JH; Lopez-Lazaro, L; Rademaker-Lakhai, JM; Rosing, H; Schellens, JH	1

Reviews

2 review(s) available for ecteinascidin 743 and Synovioma

Article	Year
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives. Current treatment options in oncology, 2021, 10-23, Volume: 22, Issue:12 Topics: Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Epigenomics; Gene Expression Regulation, Neoplastic; Genomics; Humans; Ifosfamide; Indazoles; Molecular Targeted Therapy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Soft Tissue Neoplasms; Sulfonamides; Surgical Procedures, Operative; Trabectedin	2021
Systemic Treatment for Adults with Synovial Sarcoma. Current treatment options in oncology, 2018, 03-07, Volume: 19, Issue:2 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Indazoles; Pyrimidines; Sarcoma, Synovial; Sulfonamides; Trabectedin	2018

Article

Year

The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.

Current treatment options in oncology, 2021, 10-23, Volume: 22, Issue:12

Topics: Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Epigenomics; Gene Expression Regulation, Neoplastic; Genomics; Humans; Ifosfamide; Indazoles; Molecular Targeted Therapy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Soft Tissue Neoplasms; Sulfonamides; Surgical Procedures, Operative; Trabectedin

2021

Systemic Treatment for Adults with Synovial Sarcoma.

Current treatment options in oncology, 2018, 03-07, Volume: 19, Issue:2

Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Indazoles; Pyrimidines; Sarcoma, Synovial; Sulfonamides; Trabectedin

2018

Trials

1 trial(s) available for ecteinascidin 743 and Synovioma

Article	Year
Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer. Investigational new drugs, 2005, Volume: 23, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Dioxoles; Feces; Female; Half-Life; Humans; Isoquinolines; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma; Sarcoma, Synovial; Tetrahydroisoquinolines; Trabectedin	2005

Article

Year

Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer.

Investigational new drugs, 2005, Volume: 23, Issue:5

Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Dioxoles; Feces; Female; Half-Life; Humans; Isoquinolines; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma; Sarcoma, Synovial; Tetrahydroisoquinolines; Trabectedin

2005

Other Studies

4 other study(ies) available for ecteinascidin 743 and Synovioma

Article	Year
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases. Anti-cancer drugs, 2014, Volume: 25, Issue:10 Topics: Adult; Antineoplastic Agents; Axilla; Combined Modality Therapy; Dioxoles; Epirubicin; Fatal Outcome; Humans; Ifosfamide; Lung Neoplasms; Male; Niacinamide; Phenylurea Compounds; Sarcoma, Synovial; Sorafenib; Tetrahydroisoquinolines; Trabectedin	2014
Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network. Anti-cancer drugs, 2015, Volume: 26, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dioxoles; Female; Humans; Male; Middle Aged; Retrospective Studies; Sarcoma, Synovial; Tetrahydroisoquinolines; Trabectedin	2015
Trabectedin clinical cases: use according to indication in diverse clinical scenarios. Future oncology (London, England), 2015, Volume: 11, Issue:11 Suppl Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Contraindications; Dacarbazine; Deoxycytidine; Dioxoles; Female; Femoral Neoplasms; Gemcitabine; Humans; Hysterectomy; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Thigh; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome; Uterine Neoplasms	2015
Trabectedin is a promising antitumour agent for synovial sarcoma. Journal of chemotherapy (Florence, Italy), 2016, Volume: 28, Issue:5 Topics: Adolescent; Adult; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; BRCA1 Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dioxoles; DNA-Binding Proteins; Endonucleases; Female; Flow Cytometry; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Nuclear Proteins; Sarcoma, Synovial; Tetrahydroisoquinolines; Trabectedin; Transcription Factors; Xenograft Model Antitumor Assays; Young Adult	2016